Legislation Details

File #: 26-3244    Version: 1 Name:
Type: Grant Status: Passed
File created: 5/6/2026 In control: Commissioners Court
On agenda: 5/14/2026 Final action: 5/14/2026
Title: Request by the Institute of Forensic Sciences for approval to accept from the US Department of Justice grant funds in the amount of $903,154, with no required match, for the FY2025 DNA Capacity Enhancement for Backlog Reduction Program.
Attachments: 1. 26-3244-Award Package.pdf
Primary Department: Institute of Forensic Sciences
Primary Department Head/Elected Official: Pramod Gumpeni, M.D., Executive Director & Chief Medical Examiner

Secondary Department: Choose an item.
Secondary Department Head/Elected Official:

Regular or Supplemental RCA: Supplemental RCA

Type of Request: Grant - Award

Project ID (if applicable): 15PBJA-25-GG-02000-DNAX
Vendor/Entity Legal Name (if applicable): Department of Justice

MWBE Contracted Goal (if applicable):
MWBE Current Participation (if applicable): N/A
Justification for 0% MWBE Participation Goal: N/A - Goal not applicable to request

Grant Indirect Costs Rate (if applicable): 5%
Justification for 0% Grant Indirect Costs Rate (if applicable): Choose an item.

Request Summary (Agenda Caption):
title
Request by the Institute of Forensic Sciences for approval to accept from the US Department of Justice grant funds in the amount of $903,154, with no required match, for the FY2025 DNA Capacity Enhancement for Backlog Reduction Program.
end

Background and Discussion:
The goal of this project is to provide assistance for minimizing backlogs by either implementation of new systems or directly impacting existing systems through overtime, training, and purchase of supplies, software and equipment.

Expected Impact:
The capacity exists to handle current throughput; however, persistent backlogs are present and can be eliminated with this program. This program is in alignment with HCIFS's goal to continue backlog reduction initiatives while maintaining industry-accepted professional practices and complying with applicable statutory, regulatory, safety and accreditation requirements. Note: DOJ defines "backlog" as all cases in the laboratory. In monthly reports to Commissioners, HCIFS separately reports cases in progress and un-started cases; we term un-started cases "backlog." In other words, the case backlog is the sum of un-started cases and cases-in-progress.


Alternative Options: There are f...

Click here for full text